Fulcrum Therapeutics Inc (FULC)
9.45
-0.01
(-0.11%)
USD |
NASDAQ |
Mar 28, 16:00
9.44
-0.01
(-0.11%)
After-Hours: 20:00
Fulcrum Therapeutics Total Assets (Quarterly): 257.69M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 257.69M |
September 30, 2023 | 278.88M |
June 30, 2023 | 300.33M |
March 31, 2023 | 321.12M |
December 31, 2022 | 226.68M |
September 30, 2022 | 247.80M |
June 30, 2022 | 195.23M |
March 31, 2022 | 220.25M |
December 31, 2021 | 235.00M |
September 30, 2021 | 255.55M |
June 30, 2021 | 137.88M |
Date | Value |
---|---|
March 31, 2021 | 156.48M |
December 31, 2020 | 129.58M |
September 30, 2020 | 142.22M |
June 30, 2020 | 144.86M |
March 31, 2020 | 94.86M |
December 31, 2019 | 110.44M |
September 30, 2019 | 115.96M |
June 30, 2019 | 65.15M |
March 31, 2019 | 75.59M |
December 31, 2018 | 85.77M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
65.15M
Minimum
Jun 2019
321.12M
Maximum
Mar 2023
185.58M
Average
175.85M
Median
Total Assets (Quarterly) Benchmarks
Pfizer Inc | 226.50B |
NovaBay Pharmaceuticals Inc | 12.85M |
Palatin Technologies Inc | 13.55M |
iBio Inc | 34.02M |
Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 22.50M |
Shareholders Equity (Quarterly) | 235.19M |
Current Ratio | 17.71 |